Trends in ACEi and ARB expenditure: Compelling case for competition in generic drug markets.

Batty, Jonathan A; Hall, Marlous

Batty, Jonathan A; Hall, Marlous.

Afiliação

Batty JA; Clinical and Population Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Worsley Building, Clarendon Way, University of Leeds, LS2 9NL, UK; Leeds Institute for Data Analytics, Worsley Building, Clarendon Way, University of Leeds, LS2 9NL, UK. Electronic address: J.Batty@leeds.ac.uk.
Hall M; Clinical and Population Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Worsley Building, Clarendon Way, University of Leeds, LS2 9NL, UK; Leeds Institute for Data Analytics, Worsley Building, Clarendon Way, University of Leeds, LS2 9NL, UK.

Int J Cardiol ; 370: 419-420, 2023 Jan 01.

Article em En | MEDLINE | ID: mdl-36414045

Assuntos

Antagonistas de Receptores de Angiotensina; Inibidores da Enzima Conversora de Angiotensina; Humanos; Inibidores da Enzima Conversora de Angiotensina/uso terapêutico; Medicamentos Genéricos; Bloqueadores do Receptor Tipo 1 de Angiotensina II; Gastos em Saúde

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Antagonistas de Receptores de Angiotensina Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google